Brief: PTT Says On 18 Nov, Approved Unit To Acquire All Stakes In Alvogen Emerging Markets Holdings
Nov 26 (Reuters) - PTT:
* ON 18 NOV, APPROVED UNIT TO ACQUIRE ALL STAKES IN ALVOGEN
EMERGING MARKETS HOLDINGS
* DEAL FOR ABOUT US$475 MILLION
* DEAL WITH AZTIQ HK LTD THRU AZTIQ II HOLDCO LTD AND AZTIQ
II
BIDCO LTD
* AFTER DEAL UNIT WILL HAVE INDIRECT HOLDING IN LOTUS
PHARMACEUTICAL OF ABOUT 37% AND 60% OF TOTAL ISSUED CAPITAL IN
ADALVO
Source text for Eikon: ID:nSET4Nw2fa
Further company coverage: PTT.BK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lotus Pharmaceutical
See all newsMedia: PTT is said to consider options for Taiwan-listed Lotus Pharma - Bloomberg News
Brief: enz Therapeutics Submits NDA for LNZ100 (Vizz) in South Korea to Treat Presbyopia
Brief: Lotus Pharmaceutical Says Unit Has Closed Deal In Vietnam
Brief: Fuji Pharma: Marketing Approval For Generic Lenalidomide, The First Collaboration Product With Taiwan's Lotus
Brief: Amarin And Lotus Pharmaceuticals Announce Exclusive Partnership In Southeast Asia And South Korea